Showing results (261-270 of 392) with videos related to
Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma NetworkEva Hoster, Wolfram Klapper, Olivier Hermine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemiaWilliam G Wierda, Thomas J Kipps, Jirí Mayer, et al.The Lancet. Haematology|February 3, 2022
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trialsDominic Kaddu-Mulindwa, Bettina Altmann, Sandra Robrecht, et al.Haematologica|November 10, 2018
The involvement of microRNA in the pathogenesis of Richter syndromeKatrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, et al.Genome Medicine|March 20, 2020
Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLLJustyna A Wierzbinska, Reka Toth, Naveed Ishaque, et al.The Lancet. Haematology|August 27, 2021
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trialAnna-Katharina Zoellner, Michael Unterhalt, Stephan Stilgenbauer, et al.The Lancet. Oncology|August 18, 2018
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trialPaula Cramer, Julia von Tresckow, Jasmin Bahlo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2021
Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 StudyOthman Al-Sawaf, Can Zhang, Tong Lu, et al.Nature Communications|October 20, 2022
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escapeMaurizio Mangolini, Alba Maiques-Diaz, Stella Charalampopoulou, et al.Blood|May 7, 2014
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemiaNatali Pflug, Jasmin Bahlo, Tait D Shanafelt, et al.Pageof 40